Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ)
CNY 5.88
(3.34%)
CNY 5.88
(3.34%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 898.61 Million CNY | 42.7% |
| 2022 | 666.85 Million CNY | -8.96% |
| 2021 | 732.46 Million CNY | 15.64% |
| 2020 | 633.37 Million CNY | -28.38% |
| 2019 | 884.37 Million CNY | -5.05% |
| 2018 | 931.37 Million CNY | -3.45% |
| 2017 | 964.61 Million CNY | 7.07% |
| 2016 | 900.93 Million CNY | 6.81% |
| 2015 | 843.51 Million CNY | -1.79% |
| 2014 | 858.9 Million CNY | 9.33% |
| 2013 | 785.62 Million CNY | 15.6% |
| 2012 | 679.6 Million CNY | 33.9% |
| 2011 | 507.53 Million CNY | 34.01% |
| 2010 | 378.71 Million CNY | 21.14% |
| 2009 | 312.61 Million CNY | 22.71% |
| 2008 | 254.76 Million CNY | 50.24% |
| 2007 | 169.56 Million CNY | 42.12% |
| 2006 | 119.31 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 165.93 Million CNY | -36.02% |
| 2024 Q2 | 231.05 Million CNY | -21.57% |
| 2024 Q1 | 294.6 Million CNY | 22.96% |
| 2023 Q1 | 282.31 Million CNY | 79.38% |
| 2023 Q4 | 239.59 Million CNY | 26.97% |
| 2023 FY | 951.56 Million CNY | 42.7% |
| 2023 Q3 | 188.69 Million CNY | -21.69% |
| 2023 Q2 | 240.95 Million CNY | -14.65% |
| 2022 Q4 | 157.38 Million CNY | -10.78% |
| 2022 Q1 | 205.46 Million CNY | -5.45% |
| 2022 Q2 | 127.59 Million CNY | -37.9% |
| 2022 Q3 | 176.4 Million CNY | 38.26% |
| 2022 FY | 666.85 Million CNY | -8.96% |
| 2021 FY | 732.46 Million CNY | 15.64% |
| 2021 Q4 | 217.3 Million CNY | 28.17% |
| 2021 Q1 | 208.04 Million CNY | -3.03% |
| 2021 Q3 | 169.53 Million CNY | 23.23% |
| 2021 Q2 | 137.57 Million CNY | -33.87% |
| 2020 Q2 | 129.43 Million CNY | -28.02% |
| 2020 FY | 633.37 Million CNY | -28.38% |
| 2020 Q4 | 214.55 Million CNY | 95.86% |
| 2020 Q3 | 109.54 Million CNY | -15.37% |
| 2020 Q1 | 179.82 Million CNY | -21.0% |
| 2019 FY | 884.37 Million CNY | -5.05% |
| 2019 Q4 | 227.62 Million CNY | 28.99% |
| 2019 Q3 | 176.46 Million CNY | -23.41% |
| 2019 Q2 | 230.39 Million CNY | -7.8% |
| 2019 Q1 | 249.88 Million CNY | 2.96% |
| 2018 Q3 | 138.16 Million CNY | -38.06% |
| 2018 FY | 931.37 Million CNY | -3.45% |
| 2018 Q4 | 242.69 Million CNY | 75.66% |
| 2018 Q1 | 327.47 Million CNY | 29.58% |
| 2018 Q2 | 223.04 Million CNY | -31.89% |
| 2017 Q1 | 261.62 Million CNY | 19.7% |
| 2017 Q3 | 185.55 Million CNY | -29.9% |
| 2017 Q4 | 252.71 Million CNY | 36.2% |
| 2017 FY | 964.61 Million CNY | 7.07% |
| 2017 Q2 | 264.7 Million CNY | 1.18% |
| 2016 Q1 | 249.8 Million CNY | 46.46% |
| 2016 Q3 | 173.32 Million CNY | -33.14% |
| 2016 Q4 | 218.57 Million CNY | 26.11% |
| 2016 FY | 900.93 Million CNY | 6.81% |
| 2016 Q2 | 259.23 Million CNY | 3.77% |
| 2015 FY | 843.51 Million CNY | -1.79% |
| 2015 Q4 | 170.56 Million CNY | 12.54% |
| 2015 Q3 | 151.56 Million CNY | -44.8% |
| 2015 Q2 | 274.56 Million CNY | 11.24% |
| 2015 Q1 | 246.81 Million CNY | 17.42% |
| 2014 Q4 | 210.19 Million CNY | 17.16% |
| 2014 Q3 | 179.4 Million CNY | -26.27% |
| 2014 Q2 | 243.32 Million CNY | 7.67% |
| 2014 FY | 858.9 Million CNY | 9.33% |
| 2014 Q1 | 225.98 Million CNY | 33.16% |
| 2013 Q1 | 205.03 Million CNY | 38.2% |
| 2013 FY | 785.62 Million CNY | 15.6% |
| 2013 Q4 | 169.7 Million CNY | -10.24% |
| 2013 Q3 | 189.05 Million CNY | -14.77% |
| 2013 Q2 | 221.82 Million CNY | 8.19% |
| 2012 Q1 | 165.15 Million CNY | 13.61% |
| 2012 Q2 | 192.51 Million CNY | 16.57% |
| 2012 Q3 | 173.57 Million CNY | -9.84% |
| 2012 Q4 | 148.36 Million CNY | -14.53% |
| 2012 FY | 679.6 Million CNY | 33.9% |
| 2011 Q2 | 129.41 Million CNY | 10.71% |
| 2011 FY | 507.53 Million CNY | 34.01% |
| 2011 Q4 | 145.37 Million CNY | 25.49% |
| 2011 Q1 | 116.9 Million CNY | -13.72% |
| 2011 Q3 | 115.84 Million CNY | -10.49% |
| 2010 Q1 | 69.9 Million CNY | -24.44% |
| 2010 Q4 | 135.49 Million CNY | 42.4% |
| 2010 Q3 | 95.14 Million CNY | 21.71% |
| 2010 FY | 378.71 Million CNY | 21.14% |
| 2010 Q2 | 78.17 Million CNY | 11.83% |
| 2009 Q3 | 80.62 Million CNY | 10.82% |
| 2009 Q4 | 92.51 Million CNY | 14.75% |
| 2009 FY | 312.61 Million CNY | 22.71% |
| 2009 Q2 | 72.75 Million CNY | 9.04% |
| 2009 Q1 | 66.72 Million CNY | -7.52% |
| 2008 Q4 | 72.15 Million CNY | 11.95% |
| 2008 FY | 254.76 Million CNY | 50.24% |
| 2008 Q3 | 64.45 Million CNY | 0.0% |
| 2007 FY | 169.56 Million CNY | 42.12% |
| 2006 FY | 119.31 Million CNY | 0.0% |